Monday, June 30, 2014
Worldwide Prescription Drug Sales is Expected to rise more than Trillion Dollars by 2020
Evaluate Pharma reports that the market for prescription drugs, based on the consensus forecast for the leading 500 pharmaceutical and biotechnology companies, will grow by 5.1% per year (CAGR) to reach $1,017 bn. by 2020. Worldwide prescription growth was an uninspiring 0.3% in 2013, close to the 0.4% predicted in the previous edition of the World Preview report. This represents a return to modest growth versus the 1.6% contraction in 2012. The depreciation of the yen against the dollar has negatively impacted Japan's contribution to the worldwide market in 2013 by around $15bn. Sales at risk from patent expiries will average $3bn. per year to 2020; however, as an increasing proportion of sales are from biological products, the predicted erosion post-expiration is expected to be softer, thus protecting industry growth.
Worldwide Prescription Drug Sales in 2020: Top 20 Companies
1 Novartis 2 Roche 3 Sanofi 4 Pfizer 5 GlaxoSmithKline 6 Merck & Co.
7 Johnson & Johnson 8 AstraZeneca 9 Novo Nordisk 10 Gilead Sciences
11 AbbVie 12 Bayer 13 Bristol-Myers Squibb 14 Amgen 15 Takeda
16 Eli Lilly 17 Boehringer Ingelheim 18 Teva Pharmaceutical Industries
19 Astellas Pharma 20 Biogen Idec